Savella is commonly prescribed for the treatment of fibromyalgia. This page from the eMedTV archives describes the effects of the drug, explores how it works, offers general dosing information, lists potential side effects, and more.
Common Savella side effects may include insomnia, constipation, and dizziness. This eMedTV article also lists urinary or sexual side effects that were reported in men using this drug and explains which side effects require immediate medical attention.
Insomnia is one of the most common side effects that have been reported with Savella (milnacipran). This eMedTV resource offers more information about Savella and insomnia, and provides some tips for improving your sleep habits.
Savella is used for reducing pain and improving physical functioning in people with fibromyalgia. This eMedTV Web page explores how the medication works, lists possible off-label uses, and explains whether Savella is approved for children.
There is a specific set of dosing guidelines when using Savella to treat fibromyalgia. This article from the eMedTV library explains what the standard recommended Savella dosage are for day one through day seven (and beyond) of fibromyalgia treatment.
If lithium, digoxin, or triptans are taken with Savella, drug interactions could occur. This eMedTV resource provides a more detailed list of drugs that may interact with Savella and explains what may happen if these medicines are taken together.
Talk to your doctor before using Savella if you have glaucoma. This eMedTV segment lists other conditions that you should tell your doctor about before starting Savella. Warnings and precautions on who should not use this drug are also included.
Drowsiness, dizziness, and confusion are possible indications a person has taken too much Savella. This eMedTV segment lists other possible Savella overdose symptoms and describes the steps that a doctor may take to treat an overdose.
The full risks of using Savella (milnacipran) during pregnancy are not known at this time. This eMedTV Web page includes more information on this topic and explains what happened when the drug was given to pregnant animals in clinical studies.
At this time, it is not known whether Savella (milnacipran) passes through breast milk in humans. This eMedTV article offers a more in-depth look at Savella and breastfeeding, and discusses some of the risks of using this medication while nursing.
This eMedTV article explains why there is no generic Savella (milnacipran) available at this time and explores when a generic version of the drug may be available. This page also explains the difference between a generic name and a generic version.
